International Clinical Trial: A single-center, open-label, randomized, single-dose, two-period, two-way crossover bioequivalence pre-trial of pentoxifylline sustained-release tablets under fasting and postprandial conditions in healthy test subjects

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121766) titled 'A single-center, open-label, randomized, single-dose, two-period, two-way crossover bioequivalence pre-trial of pentoxifylline sustained-release tablets under fasting and postprandial conditions in healthy test subjects' on April 2.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: The Affiliated Panyu Central Hospital, Guangzhou Medical University

Condition: None

Intervention: R-T group:Fast-fasting administration test: During the first cycle, 6 participants in the test group took 1 tablet (0.4g) of the test formulation (T) orally on an empty stomach, swallowing it whole and taki...